TheNFAPost Podcast

Calibre Scientific has announced the acquisition of LINARIS Biologische Produkte, a life science distributor with headquarters outside of Frankfurt, Germany.

LINARIS will be integrated with BIOZOL Diagnostica GmbH, a subsidiary of Calibre Scientific, enhancing its sales capabilities and product range for customers in the DACH region, a release said.

LINARIS is a specialised distributor of a comprehensive product offering that includes antibodies, proteins, ELISA kits, and reagents from leading global manufacturers. For over 30 years, customers from top German universities, hospitals, research institutes, pathology labs, and pharma and biotech companies have trusted LINARIS to provide quality products coupled with knowledgeable technical support from their team.

With this acquisition, BIOZOL further enhances its leading position in the German research and diagnostics market, as LINARIS brings new supplier relationships and product expertise that complement BIOZOL’s current capabilities.

“We are very excited about this acquisition,” said Jonas Bäuerle, Managing Director of BIOZOL.

“With LINARIS, we will expand our catalogue of high-quality life science products and introduce them to our broad customer base, to further solidify our position as the premier independent distribution platform in the DACH region for the world’s leading manufacturers.”

Peter Harbarth, Managing Director & CEO of LINARIS said, “Calibre Scientific has built a unique platform in the life science and diagnostics space: with this transition, I have the utmost confidence that the company I founded three decades ago will be in good hands for decades to come. BIOZOL has deep expertise in our market, and I trust them to carry on my mission of providing excellent products and service to our customers.”

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities.

Calibre Scientific owns a portfolio of 18 life science and diagnostic companies that have an unrivaled ability to address the unique challenges of their respective markets.

 

Previous articleNavi General Insurance Launches Subscription-based Health Insurance Through Monthly EMIs
Next articleEaton Appoints Debasish Banerji As India Director, Sales and Service, Power Quality Division

LEAVE A REPLY

Please enter your comment!
Please enter your name here